News

Under the agreement, LEO Pharma’s clinical expertise and Intomics technology in analyzing biological data will be combined to help the LEO Pharma quickly develop better and safer drugs.

Headquartered in Norcross, GA, Spear has been instrumental in helping the client develop and implement comprehensive project controls programs including methods, procedures, processes and systems. Currently, Spear is

Limerick BioPharma said that LIM-0705 is a small-molecule compound being developed to administer alongside tacrolimus, a calcineurin inhibitor widely used to block the body from rejecting transplanted organs.

LCT Biomedical was formed in 2009 to facilitate the commercial development of Diabecell in Russia. Diabecell is designed to normalise the lives of people with insulin dependent diabetes.

The new R&D facility will service international biologic developments, with combined volumes of bioreactors up to 20,000lt in multiple production lines (trains). Julius Li, CEO of AutekBio, said

In the executive board Mr Oleas will be responsible for GEA Farm Technologies and GEA Heat Exchangers segments. He has been a member of the company’s executive board

Allergan said that Botox is a prescription-only medical product that contains tiny amounts of highly purified botulinum toxin protein refined from Clostridium botulinum. Botox has a protected molecular

Affymax said that the milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan. Hematide

The newly established SVA for both solution and lyophilized vials, which is anticipated to be begin operations by the end of 2010, will add to the current sterile